Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
It is not a longer-acting Zepbound
The Food and Drug Administration (FDA) has approved Ozempic for weight loss purposes, making it a viable option for individuals struggling with obesity
Discontinuation rates due to adverse events were 12.2% and 18.2% with retatrutide 9 mg and 12 mg, respectively, compared to 4.0% with placebo
Retatrutide suppresses appetite significantly
US$ 22.06
US$ 29.07
US$ 27.21
